Premium
Oncology chain HealthCare Global Enterprises Ltd (HCG) was the only firm in the healthcare sector last year that failed to enthuse investors on its stock-market debut as its shares slumped almost 22%. However, its shares have surpassed the IPO price over the past year. In an interview with VCCircle, HCG ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
